Johnson & Johnson (J&J) announced a global hip replacement settlement for its DePuy Orthopaedics Articular Surface Replacement (ASR) hip implant in November 2013. J&J issued a recall of this device in 2010 after receiving multiple reports about failed hip implants.
The problem was not limited to ASR, however. The U.S. Food and Drug Administration (FDA) received similar complaints involving other metal-on-metal hip implants, including another DePuy metal-on-metal hip — the Pinnacle. The FDA responded in May 2011 by ordering all manufactures to conduct post market studies of their devices.
Rather than issue a DePuy hip replacement recall for the Pinnacle, J&J discontinued sale of the device in August 2013.
DePuy Pinnacle hip replacement recipients who underwent a hip revision surgery may be entitled to compensation. Patients who suspect their implant is failing are urged to contact a qualified lawyer to find out if they have a Pinnacle hip replacement lawsuit.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.